Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.

President Trump wants to end homelessness in America. His plan? Make it easier to involuntarily treat people with serious ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

The FDA is spreading lies about medications people need—and starting their attack by targeting pregnant women.

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

Democrats have accused Robert Kennedy Jr. of making claims without scientific research to back them and say his claims are ...

When the U.S. Food and Drug Administration (FDA) convened a public expert panel to review the use of selective serotonin ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.

On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an initiative that will apply to drugs that administration officials ...

The U.S. Food and Drug Administration (FDA) has stepped up warnings about tianeptine, an unapproved antidepressant increasingly sold in gas stations and convenience stores under names like "Zaza ...